The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary clinical and pathologic characteristics of patients treated in second-line (2L) with 25 cycles (Cy) or more of FOLFIRI + Aflibercept (FA).
 
Carles Pericay
No Relationships to Disclose
 
Nieves Purificacion Martinez
No Relationships to Disclose
 
Monica Corral
No Relationships to Disclose
 
Ismael Macias
No Relationships to Disclose
 
Olga Donnay
No Relationships to Disclose
 
Ignacio Juez
No Relationships to Disclose
 
Beatriz García-Paredes
Research Funding - Bayer (Inst)
 
Jose Carlos Mendez
No Relationships to Disclose
 
Diego Cacho
No Relationships to Disclose
 
Beatriz Gonzalez Astorga
No Relationships to Disclose
 
Ana Ruiz
Consulting or Advisory Role - Gilead Sciences
Expert Testimony - Amgen; Bayer; Roche; Sanofi
Travel, Accommodations, Expenses - Amgen; Roche; Sanofi
 
Mayte Delgado
No Relationships to Disclose
 
Nuria Rodriguez
No Relationships to Disclose
 
Veronica Calderero
No Relationships to Disclose
 
Elena Mata
No Relationships to Disclose
 
Juan Antonio Barrera Ramirez
No Relationships to Disclose